NeuroSense Therapeutics
focused pipeline go | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2024
Slide
4 of 27
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
January 2024
focused pipeline discovery preclinical phases phase phases next als | NeuroSense Therapeutics
Investor Presentation
December 2023
focused pipeline | NeuroSense Therapeutics
Investor Presentation
June 2023
is a leader in developing novel combination therapies for als and other neurodegenerative diseases | NeuroSense Therapeutics
Related slides by other companies
argenx SE
Results
July 2022
progressing toward | argenx SE
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
pipeline a mash obesity | NeuroBo Pharmaceuticals
Dare Bioscience
Investor Presentation
February 2023
dar working to accelerate innovation in women health upcoming program milestones dare | Dare Bioscience
Ocuphire Pharma
Results
March 2022
program evaluating for the reversal of mydriasis | Ocuphire Pharma
Other recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights